MYGN - Latest News

Myriad Genetics, Inc. (MYGN), operates in Healthcare / Medical - Diagnostics & Research, trades on NASDAQ.

Market capitalization stands near $555.4M. Beta to the broader market is 1.64.

The article list below shows the most recent MYGN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent MYGN Headlines

Myriad (MYGN) Soars 8.3%: Is Further Upside Left in the Stock?

zacks.com - Jun 29, 2026

Myriad (MYGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the

Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication

globenewswire.com - Jun 23, 2026

Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD Publication of MONITOR-Breast study marks latest miles

Should You Add Myriad Genetics Stock to Your Portfolio Right Now?

zacks.com - Jun 9, 2026

MYGN is gearing up with oncology testing and steady product launches, backed by sound solvency, though foreign-exchange swings could weigh on results.

Myriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?

zacks.com - Jun 4, 2026

Myriad (MYGN) reported earnings 30 days ago. What's next for the stock?

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026

zacks.com - Jun 2, 2026

Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like PACB, MYGN and TWST.

How News Affects MYGN Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MYGN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked MYGN news questions

What is the latest MYGN news headline?

The most recent MYGN headline (Jun 29, 2026) is "Myriad (MYGN) Soars 8.3%: Is Further Upside Left in the Stock?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the MYGN news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What MYGN news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual MYGN options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.